ODI Pharma AB (publ) (NGM:ODI)
3.000
+0.020 (0.67%)
At close: Jun 12, 2026
ODI Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is July - June.
Millions SEK. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 4.19 | 1.48 | 2.64 | 6.49 | 7.36 | 14.62 |
Cash & Short-Term Investments | 4.19 | 1.48 | 2.64 | 6.49 | 7.36 | 14.62 |
Cash Growth | 108.96% | -43.87% | -59.28% | -11.76% | -49.69% | -28.71% |
Accounts Receivable | 5.23 | 0.12 | 8.07 | 0.13 | 0.11 | - |
Other Receivables | 0.61 | 1.38 | 0.91 | 0.68 | 0.99 | 0.93 |
Receivables | 5.84 | 1.49 | 8.98 | 0.81 | 1.09 | 0.93 |
Inventory | - | - | - | 0.81 | 1.43 | 1.05 |
Prepaid Expenses | 0.49 | 0.63 | 0.59 | 0.06 | - | - |
Other Current Assets | - | - | - | 0 | 0.6 | 0.26 |
Total Current Assets | 10.51 | 3.61 | 12.22 | 8.18 | 10.48 | 16.87 |
Property, Plant & Equipment | 0.01 | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
Other Long-Term Assets | - | 1 | 0 | - | - | - |
Total Assets | 10.53 | 4.61 | 12.23 | 8.19 | 10.5 | 16.88 |
Accounts Payable | 5.83 | 0.39 | 5 | 0.71 | 0.67 | 0.15 |
Accrued Expenses | 0.79 | 1.01 | 1.16 | 0.35 | - | - |
Current Income Taxes Payable | - | 0 | 0.09 | 0 | - | - |
Current Unearned Revenue | - | - | - | - | 0.55 | 0.4 |
Other Current Liabilities | 2.12 | 2.79 | 3.98 | 4.54 | 0.01 | 0.04 |
Total Current Liabilities | 8.74 | 4.19 | 10.23 | 5.61 | 1.24 | 0.58 |
Total Liabilities | 8.74 | 4.19 | 10.23 | 5.61 | 1.24 | 0.58 |
Common Stock | 0.73 | 0.64 | 0.61 | 0.61 | 0.61 | 0.61 |
Additional Paid-In Capital | 27.08 | 25.96 | 21.84 | 21.84 | 21.84 | 21.84 |
Comprehensive Income & Other | -26.02 | -26.17 | -20.45 | -19.88 | -13.19 | -6.15 |
Shareholders' Equity | 1.79 | 0.42 | 2 | 2.57 | 9.26 | 16.3 |
Total Liabilities & Equity | 10.53 | 4.61 | 12.23 | 8.19 | 10.5 | 16.88 |
Net Cash (Debt) | 4.19 | 1.48 | 2.64 | 6.49 | 7.36 | 14.62 |
Net Cash Growth | 108.96% | -43.87% | -59.28% | -11.76% | -49.69% | -28.71% |
Net Cash Per Share | 0.21 | 0.08 | 0.17 | 0.42 | 0.49 | 0.95 |
Filing Date Shares Outstanding | 18.33 | 18.33 | 15.22 | 15.22 | 15.22 | 15.22 |
Total Common Shares Outstanding | 18.33 | 18.33 | 15.22 | 15.22 | 15.22 | 15.22 |
Working Capital | 1.78 | -0.58 | 1.99 | 2.56 | 9.25 | 16.29 |
Book Value Per Share | 0.10 | 0.02 | 0.13 | 0.17 | 0.61 | 1.07 |
Tangible Book Value | 1.79 | 0.42 | 2 | 2.57 | 9.26 | 16.3 |
Tangible Book Value Per Share | 0.10 | 0.02 | 0.13 | 0.17 | 0.61 | 1.07 |
Machinery | - | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 |